Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00351234 · ClinicalTrials.gov registry record

Carnitine Levels and Carnitine Supplementation in Type I Diabetes

A clinical trial of Hypoglycemia and Diabetes Mellitus, Type I, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
200
Enrollment target
1
Study location

NCT00351234: Completed study of Hypoglycemia and Diabetes Mellitus, Type I, sponsored by Children's Mercy Hospital Kansas City.

NCT00351234 is a study of Hypoglycemia and Diabetes Mellitus, Type I that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 200 participants, below the 502-participant average among 40 other Hypoglycemia trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00351234, a study of Hypoglycemia and Diabetes Mellitus, Type I, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether type I diabetics with carnitine deficiency exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized hypoglycemia occurs during continuous 72-hour glucose monitoring. If they are determined to have unrecognized hypoglycemia, then oral carnitine supplementation will be given to those subjects and they will be reassessed for the number of hypoglycemic events in a 72-hour glucose monitoring.

Interventions

  • DRUG Carnitine (drug)

Study Locations (1)

Missouri

  • The Children's Mercy Hospital - Kansas City

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2004-10
Est. Completion 2007-04

What the finished NCT00351234 record still lists

NCT00351234 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 502-participant average among 40 other Hypoglycemia trials with a reported enrollment target (60% lower).

The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Carnitine (drug) is the first listed.

NCT00351234 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00351234 about?

NCT00351234 is a clinical study titled "Carnitine Levels and Carnitine Supplementation in Type I Diabetes". The purpose of this study is to determine whether type I diabetics with carnitine deficiency exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized hypoglycemia occurs during continuous 72-hour glucose monitoring. If they are determined to have unrecognized hypoglyce...

What is the current status of trial NCT00351234?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2004-10. Estimated completion is 2007-04.

What conditions does trial NCT00351234 study?

This clinical trial studies the following conditions: Hypoglycemia, Diabetes Mellitus, Type I.

What interventions are being tested in trial NCT00351234?

The interventions under investigation include: Carnitine (drug) (DRUG).

Who is sponsoring clinical trial NCT00351234?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00351234 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00351234's enrollment target sits among peer trials

200 6th of 40 higher than 35 of 40 other Hypoglycemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypoglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00351234, the US trial registry maintained by the National Library of Medicine. NCT00351234 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.